NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice

  • Fabiola Marín‐Aguilar
    Research Laboratory Oral Medicine Department University of Sevilla Sevilla Spain
  • Ana V. Lechuga‐Vieco
    Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) Madrid Spain
  • Elísabet Alcocer‐Gómez
    Departamento de Psicología Experimental Facultad de Psicología Universidad de Sevilla Seville Spain
  • Beatriz Castejón‐Vega
    Research Laboratory Oral Medicine Department University of Sevilla Sevilla Spain
  • Javier Lucas
    Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) Madrid Spain
  • Carlos Garrido
    Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) Madrid Spain
  • Alejandro Peralta‐Garcia
    Centro Andaluz de Biología del Desarrollo (CABD) Universidad Pablo de Olavide‐CSIC‐Junta de Andalucía Sevilla Spain
  • Antonio J. Pérez‐Pulido
    Centro Andaluz de Biología del Desarrollo (CABD) Universidad Pablo de Olavide‐CSIC‐Junta de Andalucía Sevilla Spain
  • Alfonso Varela‐López
    Institute of Nutrition and Food Technology "José Mataix Verdú" Department of Physiology Biomedical Research Center University of Granada Granada Spain
  • José L. Quiles
    Institute of Nutrition and Food Technology "José Mataix Verdú" Department of Physiology Biomedical Research Center University of Granada Granada Spain
  • Bernhard Ryffel
    Laboratory of Experimental and Molecular Immunology and Neurogenetics (INEM) UMR 7355 CNRS‐University of Orleans Orléans France
  • Ignacio Flores
    Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) Madrid Spain
  • Pedro Bullón
    Research Laboratory Oral Medicine Department University of Sevilla Sevilla Spain
  • Jesús Ruiz‐Cabello
    CIBER de Enfermedades Respiratorias (CIBERES) Madrid Spain
  • Mario D. Cordero
    Institute of Nutrition and Food Technology "José Mataix Verdú" Department of Physiology Biomedical Research Center University of Granada Granada Spain

説明

<jats:title>Abstract</jats:title><jats:p>While NLRP3‐inflammasome has been implicated in cardiovascular diseases, its role in physiological cardiac aging is largely unknown. During aging, many alterations occur in the organism, which are associated with progressive impairment of metabolic pathways related to insulin resistance, autophagy dysfunction, and inflammation. Here, we investigated the molecular mechanisms through which NLRP3 inhibition may attenuate cardiac aging. Ablation of NLRP3‐inflammasome protected mice from age‐related increased insulin sensitivity, reduced IGF‐1 and leptin/adiponectin ratio levels, and reduced cardiac damage with protection of the prolongation of the age‐dependent PR interval, which is associated with atrial fibrillation by cardiovascular aging and reduced telomere shortening. Furthermore, old NLRP3 KO mice showed an inhibition of the PI3K/AKT/mTOR pathway and autophagy improvement, compared with old wild mice and preserved Nampt‐mediated NAD<jats:sup>+</jats:sup> levels with increased SIRT1 protein expression. These findings suggest that suppression of NLRP3 prevented many age‐associated changes in the heart, preserved cardiac function of aged mice and increased lifespan.</jats:p>

収録刊行物

  • Aging Cell

    Aging Cell 19 (1), e13050-, 2019-10-18

    Wiley

被引用文献 (3)*注記

もっと見る

問題の指摘

ページトップへ